FindMyKOL

Alok Kothari, MD

Enriched profile

Specialist in solid tumor oncology, Hematology & Oncology (Phoenix Children's) · Phoenix Children's Hospital

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Phoenix, AZ · West · United StatesSpecialtyHematology / OncologyFocusAcute Myeloid Leukemia Research+4
Active KOLFindMyKOL type: RegionalLatest publication2025Online presenceNone verifiedPayments2022–2025NIH fundingNone on fileWhy? →

Alok Kothari is Specialist in solid tumor oncology, Hematology & Oncology (Phoenix Children's) at Phoenix Children's Hospital. OpenAlex indexes 21 publications with 274 citations (h-index 5); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.

Data verified 27 Oct 2026

Overview

Updated 28 Oct 2026

Alok Kothari, MD, is Specialist in solid tumor oncology, Hematology & Oncology (Phoenix Children's) at Phoenix Children's Hospital. The public record shows 21 publications with 274 citations (h-index 5), centered on Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Epigenetics and DNA Methylation. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 5 companies.

  • Most recent indexed publication: 2025 · Pediatric blood & cancer
  • Top research focus: Acute Myeloid Leukemia Research
  • 13 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Sarcoma3 trialsComa3 trialsWilms Tumor3 trialsNeuroblastoma2 trialsMedulloblastoma2 trialsSarcoma, Ewing2 trialsRhabdomyosarcoma2 trialsMyosarcoma2 trialsCentral Nervous System Neoplasms2 trialsTeratoma2 trialsNeuro-Oncology / Glioma2 trialsGlioma2 trialsMDS / MPN1 trialHepatoblastoma1 trialKidney Cancer / RCC1 trialPheochromocytoma1 trialCarcinoma in Situ1 trialDesmoid Tumors1 trialNeuroma1 trialHistiocytosis1 trialFibroma1 trialGanglioneuroma1 trialNephroma, Mesoblastic1 trialSeminoma1 trialEndodermal Sinus Tumor1 trialNeural Tube Defects1 trialCarcinoma, Embryonal1 trialChoriocarcinoma1 trialTeratoma, Ovarian1 trialNeoplasms, Germ Cell and Embryonal1 trialLymphoma1 trialDiffuse Intrinsic Pontine Glioma1 trialNasopharyngeal Carcinoma1 trialGanglioneuroblastoma1 trialPleuropulmonary blastoma1 trialPulmonary Blastoma1 trialEpendymoma1 trialLeukemia (AML/ALL/CML/CLL)

Research focus

OpenAlex concept fingerprint
Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationEpigenetics and DNA MethylationMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Lymphoblastic Leukemia research

Drugs & molecules

across trials, industry payments and publications
Vitrakvigeneric · LarotrectinibClinical trials—Industry payments3Publications—VIJOICEClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Children's Oncology GroupClinical trials7Industry payments—Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments3National Cancer Institute (NCI)Clinical trials2Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Washington University School of MedicineClinical trials2Industry payments—Caris MPI, Inc.Clinical trials—Industry payments1Eli Lilly and CompanyClinical trials1Industry payments—Tempus AI, IncClinical trials—Industry payments1Valent Technologies, LLCClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

274citations

Total citations across indexed works.

5h-index

Hirsch index (OpenAlex). i10-index 5.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2022–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 28 Oct 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

All 13 trial records: search, sort and filter.Explore →

Industry payments

Updated 28 Oct 2026

5 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:

All 6 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 28 Oct 2026

1 congress contribution (2025) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 28 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Most-cited works

by citation count (OpenAlex)
  1. 01
    Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation
    Article95 citations2014
    doi.org ↗
  2. 02
    Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis
    Article63 citations2019
    doi.org ↗
  3. 03
    JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells
    Article63 citations2018
    doi.org ↗
  4. 04
    Granulomatous dermatitis secondary to vemurafenib in a child with Langerhans cell histiocytosis
    Article11 citations2018
    doi.org ↗
  5. 05
    Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin
    Article11 citations2015
    doi.org ↗
All 21 cited works: search, sort and filter.Explore →

Network

Updated 28 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Grant Anthony Challen10Cates Mallaney9Hamza Celik9Elizabeth L. Ostrander6Andrew Martens6Robert James Hayashi4Ashley C. Kramer4Elizabeth M. Eultgen4Lisa M. Murray3Brett J. Loechelt3Won Kyun Koh3Alexander I. Ngwube3Jeffrey H. Davis3Jeffery M. Klco2Paul R. Haut2Jasreet Hundal2Shalini M. Shenoy2Gregory Fishberger2Christopher A. Miller2Emily Kanaya Slotkin1Stephen T. Oh1Harper N. Price1Martin G. McCabe1Erica G. Schmitt1Michela Casanova1Claudia María Valverde1Jingyu Xiang1Lucia Mirea1Naoki Iwamori1John N. Nikitas1Monica L. Hulbert1Julia Chisholm1Israel D. Andrews1Spyridon Gennatas1Carly Wujek1Alexia Francesca Bertuzzi1Maleewan Kitcharoensakkul1Eric Tycksen1Walter Patrick Devine1Rotem Fishel Ben Kenan1

Online presence

Updated 28 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    phoenixchildrens.org/find-a-doctor/alok-k-kothari-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →phoenixchildrens.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 28 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.